These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9372041)

  • 1. Causes of refractoriness to platelet transfusion.
    Friedberg RC; Mintz PD
    Curr Opin Hematol; 1995 Nov; 2(6):493-8. PubMed ID: 9372041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients.
    Vassallo RR
    Immunohematology; 2009; 25(3):119-24. PubMed ID: 20406018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary refractoriness to platelet transfusion caused by Nak(a) antibody alone.
    Fujino H; Ohta K; Taniue J; Nagao N; Hino M; Yamane T; Koh KR; Takeoka Y; Hirose A; Aoyama Y; Nakamae H; Terada Y; Takubo T; Tatsumi N
    Vox Sang; 2001 Jul; 81(1):42-4. PubMed ID: 11520415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to human platelet antigens form a significant proportion of platelet antibodies detected in Indian patients with refractoriness to platelet transfusions.
    Abraham AS; Chacko MP; Fouzia NA; Srivastava A; Daniel D
    Transfus Med; 2018 Oct; 28(5):392-397. PubMed ID: 29460307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients refractory to platelet transfusion.
    Chockalingam P; Sacher RA
    J Infus Nurs; 2007; 30(4):220-5. PubMed ID: 17667077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate-transfused patients.
    Jain N; Sarkar S; Philip J
    Immunohematology; 2014; 30(3):123-5. PubMed ID: 25695438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for managing refractoriness to platelet transfusions.
    Dan ME; Schiffer CA
    Curr Hematol Rep; 2003 Mar; 2(2):158-64. PubMed ID: 12901147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the Platelet Refractory Patient.
    Forest SK; Hod EA
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):665-77. PubMed ID: 27113003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular and total body platelet equilibrium in healthy volunteers and in thrombocytopenic patients transfused with single donor platelets.
    Brubaker DB; Marcus C; Holmes E
    Am J Hematol; 1998 Jul; 58(3):165-76. PubMed ID: 9662266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmune refractoriness to platelet transfusions.
    Sandler SG
    Curr Opin Hematol; 1997 Nov; 4(6):470-3. PubMed ID: 9359008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation.
    Taaning E; Jacobsen N
    Transplant Proc; 1994 Jun; 26(3):1826. PubMed ID: 8030157
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of HLA- and HPA--matched platelets in alloimmunized patients.
    Kekomäki R
    Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet antigens and antibody detection.
    Metcalfe P
    Vox Sang; 2004 Jul; 87 Suppl1():82-6. PubMed ID: 15200612
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of universal vs bedside leukoreductions on the alloimmunization to platelets and the platelet transfusion refractoriness.
    Mishima Y; Tsuno NH; Matsuhashi M; Yoshizato T; Sato T; Ikeda T; Watanabe-Okochi N; Nagura Y; Sone S; Kurokawa M; Okazaki H
    Transfus Apher Sci; 2015 Feb; 52(1):112-21. PubMed ID: 25467707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of platelet specific antibody (anti-Sib(a)).
    Liu D; Lu P; Wang J; Bao Y
    Chin Med J (Engl); 1996 Aug; 109(8):615-7. PubMed ID: 9206062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.